rs770891152
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_033028.5(BBS4):c.960T>A(p.Tyr320*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000287 in 1,461,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_033028.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Bardet-Biedl syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BBS4 | NM_033028.5 | c.960T>A | p.Tyr320* | stop_gained | Exon 12 of 16 | ENST00000268057.9 | NP_149017.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461890Hom.: 0 Cov.: 35 AF XY: 0.0000358 AC XY: 26AN XY: 727246 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
BBS4-related disorder Pathogenic:1
The BBS4 c.960T>A variant is predicted to result in premature protein termination (p.Tyr320*). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in BBS4 are expected to be pathogenic. This variant is interpreted as likely pathogenic. -
Bardet-Biedl syndrome 4 Pathogenic:1
- -
Bardet-Biedl syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Tyr320*) in the BBS4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BBS4 are known to be pathogenic (PMID: 11381270, 12016587, 20177705, 27894351). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with BBS4-related conditions. ClinVar contains an entry for this variant (Variation ID: 531832). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at